:format(jpeg):quality(90)/wp-content/uploads/2025/12/antrenament-oficial-fcsb-meci-steaua-rosie-belgrad-261120253-scaled-e1766172194383.jpg?#)
:format(jpeg):quality(90)/wp-content/uploads/2025/12/59855648042213222448101663810073959328900636n.jpg?#)
:format(jpeg):quality(90)/wp-content/uploads/2025/12/59865431821220884952844002627370905668230743n.jpg?#)
:format(jpeg):quality(90)/wp-content/uploads/2025/12/fcsb-rapid-bucuresti-play-off-superliga-superbet-1603202511-scaled-e1766173962907.jpg?#)
EU approves Kisunla drug for Alzheimer and #39;s with reservations
Last week, the European Union authorized the marketing of Kisunla, a drug produced by the American company Eli Lilly, for the treatment of mild cognitive impairment and early dementia caused by Alzheimer and #39;s disease.
Last week, the European Union authorized the marketing of Kisunla, a drug produced by the American company Eli Lilly, for the treatment of mild cognitive impairment and early dementia caused by Alzheimer and #39;s disease.
Care este reacția ta?
:format(jpeg):quality(80)/wp-content/uploads/2025/06/empty-parking-lot-scaled.jpg?#)
